Objectives: Post-traumatic growth (PTG) and post-traumatic depreciation (PTD) can be defined, respectively, as positive and negative changes in the aftermath of trauma. These changes can be assigned to the following domains: personal strength, relating to others, new possibilities, appreciation of life, spiritual and existential change. The aim of this study was to explore the possibility that positive and negative effects of trauma can coexist and explore the categories of effect. Methods: 72 participants were asked to recount their experience of trauma and answer questions about how it had affected their thinking about themselves and the world. Participants’ narratives were analyzed by competent judges and using Linguistic Inquiry and Word Count. Results: The domains in which positive changes were most frequently observed were Personal Strength (26.09%), Relating to Others (24.22%), and Appreciation of Life (21.12%). Negative changes mainly affected Relating to Others (33.33%) and Personal Strength (23.33%). The results were confirmed by quantitative analysis of narratives: participants’ narratives of trauma and its consequences contained more words which expressing positive emotions (1.67%) than negative emotions (0.90%), paired-sample t (60) = 9.70, p < 0.001. There were correlations between the frequency of words referring to positive emotions and PTG, r (62) = 0.39, p < 0.01, and between the frequency of words referring to negative emotions and PTG, r (62) = 0.23, p < 0.05. Conclusion: PTG and PTD can coexist and they can be regarded as outcomes of two separate processes. The study results also suggest that although PTG and PTD can coexist, they may be considered different domains of psychological functioning.
ObjectivesA growing number of studies indicate that coping with the experience of a crisis event, which causes a breach in the individual’s fundamental beliefs regarding the world and his/her place in it, can result in posttraumatic growth. Positive emotions can have an undoing effect on negative emotional arousal and broaden an individual’s scope of action, and they can foster posttraumatic growth. This study aimed to examine relations between prioritizing positivity, styles of rumination, coping strategies, and posttraumatic growth.MethodsOne hundred and sixty-four Polish adults took part in the study, filling out questionnaires to measure prioritizing positivity, hope, and self-efficacy. Twelve to fifteen months later, 104 of them accepted the invitation to the second part of the study. The participants reported the intensity of rumination associated with the most critical event in their lives, which took place between the first and second stages of the study and the coping strategies they used. Posttraumatic growth and life satisfaction were also measured.ResultsResults from hierarchical regressions found that higher levels of prioritizing positivity, deliberate ruminations, and religious coping and lower level of intrusive ruminations were associated with posttraumatic growth. The results also indicate that self-esteem was a significant predictor of life satisfaction.ConclusionsThe results of the prospective study confirm that individual differences in prioritizing positivity can relate to a process of posttraumatic growth. Prioritizing positivity was associated with the use of an active coping strategy and deliberate but not intrusive ruminations. Previous studies on the role of prioritizing positivity have focused on the impact on the level of wellbeing of seeking positive emotions in everyday life. Our results show the importance of prioritizing positivity in coping with stress and trauma. These results can be used to design effective psychological intervention techniques to support people experiencing trauma and psychological crises. The results also indicate that life satisfaction has different predictors from posttraumatic growth.
Health disorders in mothers and their children are subject to mutual influences arising from the nature of mother–child relationship. The aim of the study was to analyze the issue of anxiety amongst mothers of short children in aspect of growth hormone (GH) therapy in Poland. The study was based on a group of 101 mothers of originally short-stature children: 70 with GH deficiency treated with recombinant human GH and 31 undergoing the diagnostic process, without any treatment. Collected medical data included the child's gender, height and weight, chronological age, bone age delay, and GH therapy duration. For all children the height SDS (standard deviation score of height) and BMI SDS (standard deviation score of body mass index) were calculated. The Spielberger State-Trait Anxiety Inventory (STAI) was used to evaluate anxiety levels among the recruited mothers. Obtained results revealed low trait anxiety levels in all mothers, with no statistically significant differences between the groups. State anxiety levels were significantly higher in mothers of children without diagnosis and treatment than in mothers of children receiving appropriate therapy. Significantly lower levels of maternal state anxiety were observed during the first stage of the GH therapy, and they were further reduced in mothers of children treated for more than 4 years. Growth failure in Polish children is not associated with high maternal anxiety as a personality trait, but lack of diagnosis and lack of appropriate treatment seem to generate high levels of anxiety as a transient state in mothers. The initiation of GH therapy induces a substantial reduction of maternal state anxiety, and the duration of this treatment causes its further decrease. Mothers of short children undergoing diagnostic process could benefit from psychological support, but it seems to be unnecessary when their children are treated with GH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.